Barentz completed the acquisition of Anshul Life Sciences.

Barentz, a global specialty ingredients solution provider, completed the acquisition of Anshul Life Sciences, a high-end life science focused specialty chemicals distributor. Financial terms were not disclosed. “We are extremely excited to welcome Anshul Life Sciences to the Barentz Group. The acquisition underpins our ambitions to further grow in India, one of our key strategic markets, and the Asia Pacific region in general. The acquisition benefits our customers and principals by providing access to a broader portfolio of high-quality pharmaceuticals excipients and products and a deeper pool of expertise. We are delighted that Mr. Nagarajan will continue to lead the business. Together, we aim to enhance our offering and better serve the needs of the dynamic Indian market and beyond," Marc Duchene, Barentz CEO APAC.